About Mapmygenome India Limited
Data last updated: 06 January 2026
Mapmygenome India Limited is a public limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It specialises in diagnostic centers and pathology labs, a part of the broader healthcare sector. Incorporated on 10 February 2012, the company has been in operation for over 14 years.
Registered with ROC Hyderabad under CIN U24232AP2012PLC079091.
Capital: an authorised share capital of ₹6.5 Cr and a paid-up capital of ₹3.44 Cr. It is led by directors including Venkata Subash Lingareddy and Anuradha Acharya.
Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: Royal Demeure Plot No. 12/2 Sector – 1 Huda Techno Enclave Madhapur, Hyderabad, Telangana, India – 500081.
As per the financials filed for FY 2025, the company reported a revenue of ₹31.2 Cr, a growth of 2% compared to the previous year.
The company has a workforce of approximately 87 employees as per the latest available data.
The company is associated with 1 brand - Mapmygenome. As per MCA filings, the company has open charges of ₹10.19 Cr and satisfied charges of ₹5.69 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mapmygenome.in.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media
-
Registered AddressRoyal Demeure Plot No. 12/2 Sector – 1 Huda Techno Enclave Madhapur, Hyderabad, Telangana, India – 500081
-
IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Mapmygenome India Limited
Mapmygenome India Limited has one previous CIN (Corporate Identification Number): U24232AP2012PLC079091. The current CIN is U24232TG2012PLC079091, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2012PLC079091 | Current |
| U24232AP2012PLC079091 | Previous |
Associated Brands with Mapmygenome India Limited
Mapmygenome India Limited operates one associated brand: MapMyGenome. These brands represent Mapmygenome India Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Personal genetic testing and diagnostics services are provided. | mapmygenome.in |
Competitors & Alternatives of Mapmygenome India Limited
Brands and companies operating in the same space as Mapmygenome India Limited include Bione, Xcode Life, StellarGene and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Bione
|
Diagnostic kits for microbiome testing are developed to manage health. | Bengaluru, India, India | 2019 |
Xcode Life
|
Provider of personalized health and wellness solutions | Chennai, India, India | 2010 |
StellarGene
|
Provides comprehensive genetic testing solutions for accurate gene analysis and personalized health insights. | Delhi, India, India | 2016 |
Diagright
|
Delivers mobile apps for comprehensive body vital monitoring. | Gurugram, India, India | 2020 |
Jai Health
|
Provides genomic-based diagnostic solutions to prevent heart diseases. | Bengaluru, India, India | 2011 |
DNA Health Wellness
|
Delivers DNA testing services for personalized dietary supplements. | Delhi, India, India | 2015 |
Pregenic
|
Provides DNA testing kits and genetic analysis for health predispositions services. | Jaipur, India, India | 2022 |
Genessense
|
Offers a comprehensive genomic wellness screening platform for health insights and personalized solutions. | Bengaluru, India, India | 2013 |
Business Activity of Mapmygenome India Limited
Mapmygenome India Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | ********* |
Board of Directors of Mapmygenome India Limited
Mapmygenome India Limited is currently managed by 4 directors, with 6 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Venkata Subash Lingareddy
Also directs:
Photon Capital Advisors Limited, Coramandel Mining & Exports Private Limited, L.V.S.R. Farms Private Limited and 4 more
|
Additional Director | 14 Mar 2024 | 2 Years 3 Months | Current |
| Anuradha Acharya | Director | 20 Apr 2013 | 13 Years 2 Months | Current |
| Ramabadran Gopalakrishnan | Director | 01 Feb 2017 | 9 Years 5 Months | Current |
|
Arjun Malhotra
Also directs:
Dmi Finance Private Limited, Epic Electronics Products Foundation, Aimil Limited and 4 more
|
Director | 16 Apr 2013 | 13 Years 2 Months | Current |
Financials of Mapmygenome India Limited FY 2025 filings available
Mapmygenome India Limited reported revenue of ₹31.2 Cr (up 2% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Mapmygenome India Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Dec 2023 | Others | ₹1.22 Cr | Open |
| 08 May 2023 | Others | ₹94.88 Lakh | Open |
| 13 Jan 2023 | Hdfc Bank Limited | ₹8 Cr | Open |
| 10 Oct 2022 | Canara Bank | ₹2 Lakh | Open |
| 24 Dec 2021 | Canara Bank | ₹4.15 Cr | Satisfied |
Total charge records: 8 View all charges
Employees and EPFO Compliance at Mapmygenome India Limited
View historical data on people associated with Mapmygenome India Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Mapmygenome India Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Mapmygenome India Limited
GSTIN & GST Filing Data of Mapmygenome India Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Mapmygenome India Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Mapmygenome India Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Mapmygenome India Limited
MSME Payment Delays by Mapmygenome India Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Mapmygenome India Limited
Subsidiaries & Group Companies of Mapmygenome India Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Mapmygenome India Limited with ownership details.
MCA Filings & Documents of Mapmygenome India Limited
MCA Filings & Documents of Mapmygenome India Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Mapmygenome India Limited
Recent News on Mapmygenome India Limited
Frequently Asked Questions about Mapmygenome India Limited
Mapmygenome India Limited is an active public limited company in the healthcare sector based in Hyderabad, Telangana, India. It was incorporated on 10 February 2012 (14+ years old) and is registered under CIN U24232TG2012PLC079091. The company has 87 employees.
Mapmygenome India Limited reported revenue of ₹31.2 Cr for FY 2025 (up 2.00% YoY).
The current directors of Mapmygenome India Limited are:
The primary industry of Mapmygenome India Limited is healthcare. The company specifically operates in diagnostic centers and pathology labs. The company is currently active in this sector.
Yes, Mapmygenome India Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Mapmygenome India Limited can be reached at the registered office: Royal Demeure Plot No. 122 Sector – 1 Huda Techno Enclave Madhapur, Hyderabad, Telangana, India – 500081, or through the website mapmygenome.in.